Lo mejor del año en lupus eritematoso sistémico
- 1 January 2015
- journal article
- review article
- Published by Elsevier in Reumatología Clínica
- Vol. 11 (1), 27-32
- https://doi.org/10.1016/j.reuma.2014.09.004
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Impact of early disease factors on metabolic syndrome in systemic lupus erythematosus: data from an international inception cohortAnnals Of The Rheumatic Diseases, 2014
- Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patientsAnnals Of The Rheumatic Diseases, 2014
- A Panel of Biomarkers Is Associated With Increased Risk of the Presence and Progression of Atherosclerosis in Women With Systemic Lupus ErythematosusArthritis & Rheumatology, 2013
- Toll‐like Receptor 7–Stimulated Tumor Necrosis Factor α Causes Bone Marrow Damage in Systemic Lupus ErythematosusArthritis & Rheumatology, 2013
- Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroidsAnnals Of The Rheumatic Diseases, 2013
- Lupuzor/P140 peptide in patients with systemic lupus erythematosus: a randomised, double-blind, placebo-controlled phase IIb clinical trialAnnals Of The Rheumatic Diseases, 2012
- Predictors of organ damage in systemic lupus erythematosus: The Hopkins Lupus CohortArthritis & Rheumatism, 2012
- Early treatment with rituximab in newly diagnosed systemic lupus erythematosus patients: a steroid-sparing regimenRheumatology, 2011
- Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosusArthritis & Rheumatism, 2001
- Damage in systemic lupus erythematosus and its association with corticosteroidsArthritis & Rheumatism, 2000